[On the treatment of the respiratory distress syndrome in premature infants with tris(hydroxymethyl)-aminomethane (THAM) and wetting agents].
D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases; D007263:Infusions, Parenteral; D012127:Respiratory Distress Syndrome, Newborn / Q000628:therapy*; D012138:Respiratory Therapy; D013501:Surface-Active Agents / Q000627:therapeutic use*; D014325:Tromethamine / Q000627:therapeutic use*
D013501:Surface-Active Agents; D014325:Tromethamine
Zur Behandlung des Respiratory-Distress-Syndrome bei Frühgeborenen mit Tris-(hydroxymethyl)-aminomethan (THAM) und Netzmittel.